Replies to post #395222 on Amarin Corp Plc (AMRN)

[ramfan60]

Well Mrmain...... I am also picking off more shares as I can. You said a mouthful here.

"Is it via GIA revenue growth in the EU, some sort of AG in the US, victory in court, a buyout, or something like Denner taking control? Maybe it's a new indication or trial result?"

I think it will happen in any (and all) of the scenarios you've listed..... it's more a matter of the speed at which it will happen. If we rely on GIA, then we plod along with receiving authorization and pricing along with getting prescriptions in the ROW. We are basically break even and the US scripts are funding everything at the moment. This is the slowest route to the $5 mark but I think it alone will get us there. I think an AG helps if it can be priced near V and get the same generic tier acceptance as everyone else. A victory in court would be huge catalyst sepending on what the victory induces. A buyout speaks for itself but I don't want that until the price gets above $5 anyway. Denner taking control sounds very appealing but we really don't know what he'll do. We can only speculate that it's very positive because he's in the business of making money off of these things. Any new indication or trial result is an "it depends".

The biggest challenge still is AMRN figuring out how to sell V in every region. They have to convince those that prescribe this medicine that it is life saving/changing for their patients.

[north40000]

We bought an additional 1000 shares of Amarin yesterday at $1.18. Sold 50 SPG to finance that purchase while initiating a position in TSM at $80.15 in my IRA. Our remaining SPG shares are profitable today as are the TSM shares. Amarin shares are unchanged at yesterday’s close, $1.17.

A PR on the JNJ TDA site illustrates the market we are in, warning of a “confusing” picture of “what is making us sick.”

https://secure.tdameritrade.com/quotes/summary/JNJ#symbolNewsArticleModal

'Figuring out what's making people sick is going to be a conundrum,' Dr. Sandra Fryhofer, an internal medicine physician, said this week

A particularly challenging respiratory illness season is well underway in the U.S., and health officials are urging people to once again get vaccinated against the flu and COVID-19.

There are currently higher-than-normal levels of respiratory syncytial virus (RSV) and influenza in the U.S. right now. At the same time, the number of new COVID infections is 28% higher now than it was two weeks ago.

"It is going to be a confusing respiratory infection season," Dr. Sandra Fryhofer, an internal medicine physician at Piedmont Hospital and several other hospitals in Atlanta, told reporters on Monday. "Figuring out what's making people sick is going to be a conundrum."

Even for people who test negative for COVID, flu and RSV, it's still possible to come down with the common cold as many Americans have moved away from pandemic mitigation measures like social distancing and masking toward a post-COVID norm. It appears the number of flu cases in Europe is also higher than it was last year, according to UBS analysts.

"These levels are higher than we generally see this time of year," Centers for Disease Control and Prevention director Rochelle Walensky said during Monday's call with reporters. "Compared to the week prior, hospitalizations for flu continue to be the highest we have seen at this time of year in a decade."

An estimated 8.7 million people have gotten the flu, 78,000 people have been hospitalized with the flu, and 4,500 have died, including 14 children, since Oct. 2, according to the CDC. About 7.5% of all visits to a healthcare provider right now are for respiratory illness. (This week last year, respiratory illnesses made up 2.5% of outpatient provider visits.)

Shortages of the flu antiviral Tamiflu and the antibiotic amoxicillin have exacerbated the surge in respiratory illness. A liquid version of amoxicillin that is in short supply is commonly used to treat ear infections, pneumonia and sinusitis, which can occur as a result of an infection, according to the American Academy of Pediatrics. It's hard to track down over-the-counter medications like Children's Tylenol and Motrin in some regions.

"We continue to experience high consumer demand," a Johnson & Johnson (JNJ) spokesperson said in an email. "Some products may be less readily available due to this increased demand but we are not experiencing an overall shortage of Children's Tylenol or Children's Motrin in the United States."

There are still steps to take to prevent or reduce the risk of severe respiratory illness. The flu shots are a "good match to circulating virus," according to Fryhofer. As with the COVID vaccines, it takes about two weeks after a flu shot to build protective antibodies. The new COVID boosters, which have been updated to better protect against new omicron subvariants, are also available.

There are also antivirals that treat flu and COVID. And while there are no treatments or vaccines available for RSV at this time, several pharmaceutical companies including GlaxoSmithKline and Pfizer Inc (PFE) are seeking regulatory approval of RSV vaccines for older adults.

Walensky also noted that RSV has peaked in the South and Southeast, and it may soon peak in New England and the Midwest.

"There's probably a sense of complacency," Fryhofer said. "We've forgotten how bad flu can be. But this season is a shoutout that it can get really bad, and it's here. So people need to get vaccinated."

Read more of MarketWatch's recent coverage of viruses:

Confused about COVID boosters? Here's what the science and the experts say about the new generation of shots

COVID-19 may be to blame for the surge in RSV illness among children. Here's why

A common virus is putting more children in the hospital than in recent years

-Jaimy Lee

(END) Dow Jones Newswires

December 08, 2022 08:41 ET (13:41 GMT)

[Number sleven]

MRM, I am in the process of collecting funds.
Sleven,

[Invest83838]

Mainstreet, I shouldn't have bought as many shares as I did over the last 10 years

I currently view my total cost as "sunk cost"

Unless some miracle happens where I can at least break even

I want to believe I could at least double my money

But that is currently looking doubtful

In the meantime, I just plan to periodically bitch about the share price

to PO people like ConCap ;-)

[Nukemtiltheyglow]

MRM; already bought 2 weeks ago @ 1.12. Just sitting and waiting. Good news about Switzerland, they're flush with cash from the holocaust. Something nobody wants to talk about.

How about that Griner Trade? Something else huh?

[DAR53]

I continue to pick up shares down in the 1.17 - 1.22 over the past two months. But, I'm a lot more patient than I was 2 years when it was a daily FOMO.